New beta-lactam antibiotics in granulocytopenic patients: New options and new questions
- 9 August 1985
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 79 (2) , 75-82
- https://doi.org/10.1016/0002-9343(85)90265-7
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopeniaAntimicrobial Agents and Chemotherapy, 1984
- Moxalactam plus piperacillin versus moxalactam plus amikacin in febrile granulocytopenic patientsThe American Journal of Medicine, 1984
- Piperacillin plus vancomycin in the therapy of febrile episodes in cancer patientsAntimicrobial Agents and Chemotherapy, 1984
- Approaching the controversies in antibacterial management of cancer patientsThe American Journal of Medicine, 1984
- Significance of serum bactericidal activity in gram-negative bacillary bacteremia in patients with and without granulocytopeniaThe American Journal of Medicine, 1984
- Cefotaxime versus Ampicillin, Methicillin and Netilmicin in Combination for Treatment of Febrile Episodes in Patients with Haematologic MalignancyActa Medica Scandinavica, 1983
- Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: A Comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacinThe American Journal of Medicine, 1982
- Fever in the Pediatric and Young Adult Patient with CancerMedicine, 1982
- Piperacillin or ticarcillin plus amikacinThe American Journal of Medicine, 1981
- Increasing incidence of gram‐positive sepsis in cancer patientsMedical and Pediatric Oncology, 1978